Loading...
Loading...
Of the 5 tracked institutions holding HBIO, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +7.1pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 5 tracked institutional investors we monitor, HBIO (HARVARD BIOSCIENCE INC) is held with a combined value of $1.11M across 228,191 shares. The largest holder is RENAISSANCE TECHNOLOGIES LLC with a position worth $493.95K. 5 funds opened new positions in the most recent quarter.
Total Institutional Value
$1.11M
Total Shares Held
228,191
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $493.95K | 0.00% | New |
| 2 | BlackRock, Inc. | $303.04K | 0.00% | New |
| 3 | MILLENNIUM MANAGEMENT LLC | $225.64K | 0.00% | New |
| 4 | STATE STREET CORP | $72.72K | 0.00% | New |
| 5 | FMR LLC | $15.94K | 0.00% | New |
As of the latest SEC 13F filings, RENAISSANCE TECHNOLOGIES LLC is the largest institutional holder of HBIO with a position worth $493.95K, representing 0.00% of their portfolio. In total, 5 institutional investors hold HBIO with a combined value of $1.11M.
In the most recent quarter, 5 funds opened a new position in HBIO.
Institutional investors hold $1.11M worth of HBIO stock across 5 positions. The largest institutional holder is RENAISSANCE TECHNOLOGIES LLC with $493.95K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For HBIO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their HBIO positions.
None this quarter.
Last Close
$6.00
2026-07-24
YTD
-8.0%
54% of 52-week range